1. What impact does the SBIRT program have on patient-level outcomes?
a. What effect does screening and brief feedback have on the alcohol, marijuana, and other drug use of patients who screen negative?
b. What effect does BI have on the alcohol, marijuana, and other drug use of patients who are screened?
c. What effect does BT have on the alcohol, marijuana, and other drug use of patients?
d. What effect does full treatment received through SBIRT have on the alcohol, marijuana, and other drug use of patients?
e. What effect does SBIRT have on the education and employment status of patients?
f. What effect does SBIRT have on the criminal behavior and criminal justice involvement of patients?
g. What effect does SBIRT have on the housing arrangements and conditions in which patients live?
h. What effect does SBIRT have on patients’ perceptions of care?
2. What grantee- and practitioner-level characteristics moderate the effectiveness of SBIRT for patient-level outcomes?
3. What are the costs of SBIRT to patients?
4. Are screening, BI, BT, and referral to treatment rates correlated with practitioner characteristics?
5. What organizational (clinic, treatment setting) characteristics moderate the willingness and ability of practitioners to adopt SBIRT?
6. Who provides SBIRT services?
7. To what extent do practitioners actually perform SBIRT?
File Type | application/msword |
File Title | APPENDIX 8: |
Author | proth |
Last Modified By | proth |
File Modified | 2006-06-28 |
File Created | 2006-05-11 |